Global Biosimilar Market Demands, Trends & Opportunities, Generic Drugs and High-Entry Barriers 2015 Edition:Just Released of Marketresearchreports.biz
MarketResearchReports.Biz announces addition of new report"Global Biosimilar Market Trends & Opportunities: 2015 Edition :Market Segments, Size, Trend and Market projections for upcoming years"to its database
Albany, NY -- (SBWire) -- 03/11/2015 --Global Biosimilar Market Trends & Opportunities: 2015 Edition provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
To Read the Complete Report with Toc Visit: http://www.marketresearchreports.biz/analysis/242914
The report titled "Global Biosimilar Market: Trends & Opportunities (2015 Edition)" analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy's Lab are profiled in the report.
Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
Humira, Enbrel, Remicade, Herceptin
Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)
Dr. Reddy's Lab
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/242914
Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth. Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market. In addition, increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market.
To View The Latest News: http://www.marketresearchreports.biz/articles
The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. Globally there are 280 biosimilars in pipeline and their clinical trials are increasing at a rate of 20% annually.
The report titled "The Global Biosimilar Market: Trends & Opportunities (2014-2018)" provides an in-depth analysis of the growing Biosimilar Market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall Biosimilars industry has also been forecasted for the period 2014-18, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Sandoz, Teva, Hospira and Dr. Reddy's Lab are profiled.
Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA: Canada Toll Free: 866-997-4948
Media Relations Contact
View this press release online at: http://rwire.com/585248